Journals / Anadolu Kardiyoloji Dergisi / 2006 / Cilt: 6 - Sayı: 1

Atriyal fibrilasyonun perkütan ablasyonu: Kime ve nasıl?

Percutaneous ablation of atrial fibrillation: for whom and how?

Pages
68–73
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Complications including pulmonary vein stenosis are uncommon.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Recent developments in our understanding of atrial fibrillation (AF) have focused on the key role of pulmonary vein initiators of multiple wavelet reentry in the atria.
📊
Key Findings & Data:Success rates (AF elimination) are 90% without drugs in case of paroxysmal atrial fibrillation and 80% for persistent atrial fibrillation.
💡
Conclusion & Impact:Complications including pulmonary vein stenosis are uncommon.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Recent developments in our understanding of atrial fibrillation (AF) have focused on the key role of pulmonary vein initiators of multiple wavelet reentry in the atria. Percutaneous catheter ablation of atrial fibrillation is commonly performed by electrical disconnection of pulmonary vein myocardium from the left atrium. As a result, pulmonary vein foci can no longer drive the atria into fibrillation. At present, the procedure is offered to patients with paroxysmal atrial fibrillation refractory to multiple antiarrhythmic agents. For patients with persistent atrial fibrillation, supplementary linear lesions in the left atrium may be necessary. Success rates (AF elimination) are 90% without drugs in case of paroxysmal atrial fibrillation and 80% for persistent atrial fibrillation. Complications including pulmonary vein stenosis are uncommon.

Özet

Atriyal fibrilasyon (AF) anlayışımızda son gelişmeler pulmoner venlerin atriyumlarda çoklu “wavelet reentry”nin tetikleyici anahtar rolünde yoğunlaşmıştır. Atriyal fibrilasyonun perkütan kateter ablasyonu genellikle pulmoner ven miyokardının sol atriyal miyokardından elektriksel bağlantısının kesilmesi ile yapılmaktadır. Sonuçta, pulmoner ven odakları atriyumların fibrilasyona girmelerini sağlamaz. Bugünlerde, bu prosedür çoklu antiaritmik ilaçlara refrakter olan paroksizmal AF'li hastalara önerilmektedir. Persistan AF'li hastalar için ek olarak sol atriyumda lineer lezyonların yaratılmasına ihtiyaç duyulabilir. Başarı oranı (AF eliminasyonu) ilaçsız paroksizmal AF'li olgular icin %90 ve persistan AF için - %80'dir. Pulmoner ven darlığı ile beraber olan komplikasyonlar nadirdir.

🔖

Cite This Article

SHAH, D., DÖNMEZ, G., SUNTHORN, H., BURRI, H. (2022). Atriyal fibrilasyonun perkütan ablasyonu: Kime ve nasıl?. Anadolu Kardiyoloji Dergisi, Cilt: 6 - Sayı: 1, 68–73. https://ajindex.com/articles/437335

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Cox CL, Schuessler RB, D'Agustino HU, Stone JM, Chang BC, Cain ME, et al. The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure. J Thorac Cardiovasc Surg 1991;101: 569-83
  2. Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl Med 1998;339:659-66
  3. Ho SY, Cabrera JA, Tran VH, Farre J, Anderson RH, Sanchez-Quintana D. Architecture of the pulmonary veins: relevance to radiofrequency ablation. Heart 2001; 86: 265-70
  4. Shah DC, Haissaguerre M, Jais P, Hocini M, Macle L, Choi KJ, et al. Left atrial appendage activity masquerading as pulmonary vein activity. Circulation 2002; 105: 2821-5 5. Haissaguerre M, Shah DC, Jais P, Hocini M, Yamane T, Deisenhofer I, et al. Electrophysiological breakthroughs from the left atrium to the pulmonary veins. Circulation. 2000; 102: 2463-5
  5. Jais P, Hocini M, Macle L, Choi KJ, Deisenhofer I, Weerasoriya R et al. Distinctive electrophysiological properties of pulmonary veins in patients with atrial fibrillation. Circulation 2002; 106: 2479-85
  6. Shah DC, Haissaguerre M, Jais P, Hocini M, Yamane T, Deisenhofer I, et al. Curative catheter ablation of paroxysmal atrial fibrillation in 200 patients: Strategy for presentations ranging from sustained atrial fibrillation to no arrhythmias. Pacing Clin Electrophysiol 2001;24:1541-58
  7. Jais P, Haissaguerre M, Shah DC, Chouairi S, Gencel L, Hocini M, et al. A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation 1997; 95: 572-6
  8. Shah DC, Jais P, Haissaguerre M. Analysis of right superior pulmonary vein electrograms by 3D biatrial activation mapping. (Abstract). Pacing Clin Electrophysiol 2002; 24: 377
  9. Macle L, Jais P, Scavee, Weerasooriya R, Shah DC, Hocini M, et al. Electrophysiologically guided pulmonary vein isolation during sustained atrial fibrillation. J Cardiovasc Electrophysiol 2003;14: 255-60
  10. Taylor GW, Kay N, Zheng X, Bishop S, Ideker RE. Pathological effects of radiofrequency energy applications in the pulmonary veins in dogs. Circulation 2000; 101: 1736-42
  11. Robbins IM, Colvin EV, Doyle TP, Kemp WE, Loyd JE, McMahon WS, et al. Pulmonary vein stenosis after catheter ablation of atrial fibrillation. Circulation 1998; 98: 1769-75
  12. Pappone C, Oreto G, Rosanio S, Vicedomini G, Tocchi M, Gugliotta F, et al. Atrial electroanatomical remodeling a